Literature DB >> 27640148

C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration.

Nathan P Rudemiller1, Mehul B Patel1, Jian-Dong Zhang1, Alexander D Jeffs1, Norah S Karlovich1, Robert Griffiths1, Matthew J Kan2, Anne F Buckley3, Michael D Gunn2, Steven D Crowley4.   

Abstract

Inappropriate activation of the renin angiotensin system (RAS) is a key contributor to the pathogenesis of essential hypertension. During RAS activation, infiltration of immune cells into the kidney exacerbates hypertension and renal injury. However, the mechanisms underpinning the accumulation of mononuclear cells in the kidney after RAS stimulation remain unclear. C-C motif chemokine 5 (CCL5) drives recruitment of macrophages and T lymphocytes into injured tissues, and we have found that RAS activation induces CCL5 expression in the kidney during the pathogenesis of hypertension and renal fibrosis. We therefore evaluated the contribution of CCL5 to renal damage and fibrosis in hypertensive and normotensive models of RAS stimulation. Surprisingly, during angiotensin II-induced hypertension, CCL5-deficient (knockout, KO) mice exhibited markedly augmented kidney damage, macrophage infiltration, and expression of proinflammatory macrophage cytokines compared with wild-type controls. When subjected to the normotensive unilateral ureteral obstruction model of endogenous RAS activation, CCL5 KO mice similarly developed more severe renal fibrosis and greater accumulation of macrophages in the kidney, congruent with enhanced renal expression of the macrophage chemokine CCL2. In turn, pharmacologic inhibition of CCL2 abrogated the differences between CCL5 KO and wild-type mice in kidney fibrosis and macrophage infiltration after unilateral ureteral obstruction. These data indicate that CCL5 paradoxically limits macrophage accumulation in the injured kidney during RAS activation by constraining the proinflammatory actions of CCL2.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27640148      PMCID: PMC5222967          DOI: 10.1016/j.ajpath.2016.07.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

Authors:  G Wolf; F N Ziyadeh; F Thaiss; J Tomaszewski; R J Caron; U Wenzel; G Zahner; U Helmchen; R A Stahl
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines.

Authors:  Teresa Mateo; Yafa Naim Abu Nabah; May Abu Taha; Manuel Mata; Miguel Cerdá-Nicolás; Amanda E I Proudfoot; Rolf A K Stahl; Andrew C Issekutz; Julio Cortijo; Esteban J Morcillo; Peter J Jose; Maria-Jesus Sanz
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 4.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

5.  Immunosuppressive treatment protects against angiotensin II-induced renal damage.

Authors:  Dominik N Muller; Erdenechimeg Shagdarsuren; Joon-Keun Park; Ralf Dechend; Eero Mervaala; Franziska Hampich; Anette Fiebeler; Xinsheng Ju; Piet Finckenberg; Jürgen Theuer; Christiane Viedt; Joerg Kreuzer; Harald Heidecke; Hermann Haller; Martin Zenke; Friedrich C Luft
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  Chemokine expression in the obstructed kidney.

Authors:  J M Crisman; L L Richards; D P Valach; D F Franzoni; J R Diamond
Journal:  Exp Nephrol       Date:  2001

7.  Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.

Authors:  Shuei Liong Lin; Ana P Castaño; Brian T Nowlin; Mark L Lupher; Jeremy S Duffield
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

8.  Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis.

Authors:  Jian-dong Zhang; Mehul B Patel; Robert Griffiths; Paul C Dolber; Phillip Ruiz; Matthew A Sparks; Johannes Stegbauer; Huixia Jin; Jose A Gomez; Anne F Buckley; William S Lefler; Daian Chen; Steven D Crowley
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

9.  CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration.

Authors:  Hans-Joachim Anders; Michael Frink; Yvonne Linde; Bernard Banas; Markus Wörnle; Clemens D Cohen; Volker Vielhauer; Peter J Nelson; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

10.  Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension.

Authors:  Tomasz P Mikolajczyk; Ryszard Nosalski; Piotr Szczepaniak; Klaudia Budzyn; Grzegorz Osmenda; Dominik Skiba; Agnieszka Sagan; Jing Wu; Antony Vinh; Paul J Marvar; Bartlomiej Guzik; Jakub Podolec; Grant Drummond; Heinrich E Lob; David G Harrison; Tomasz J Guzik
Journal:  FASEB J       Date:  2016-02-12       Impact factor: 5.191

View more
  22 in total

Review 1.  Role of immune cells in hypertension.

Authors:  Antoine Caillon; Pierre Paradis; Ernesto L Schiffrin
Journal:  Br J Pharmacol       Date:  2018-07-20       Impact factor: 8.739

2.  C-C Motif Chemokine Receptor 7 Exacerbates Hypertension Through Effects on T Lymphocyte Trafficking.

Authors:  Yi Wen; Nathan P Rudemiller; Jiandong Zhang; Xiaohan Lu; Jiafa Ren; Jamie R Privratsky; Robert Griffiths; Junyi J Zhang; Gianna E Hammer; Steven D Crowley
Journal:  Hypertension       Date:  2020-01-27       Impact factor: 10.190

Review 3.  The role of chemokines in hypertension and consequent target organ damage.

Authors:  Nathan P Rudemiller; Steven D Crowley
Journal:  Pharmacol Res       Date:  2017-03-06       Impact factor: 7.658

Review 4.  Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire?

Authors:  Gabriella R Abouelkheir; Bradley D Upchurch; Joseph M Rutkowski
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-07

Review 5.  Renal effects of cytokines in hypertension.

Authors:  Yi Wen; Steven D Crowley
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

Review 6.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

7.  The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy.

Authors:  Jiafa Ren; Nathan P Rudemiller; Yi Wen; Xiaohan Lu; Jamie R Privratsky; Steven D Crowley
Journal:  Kidney Int       Date:  2019-08-13       Impact factor: 10.612

8.  Twist1 in Infiltrating Macrophages Attenuates Kidney Fibrosis via Matrix Metallopeptidase 13-Mediated Matrix Degradation.

Authors:  Jiafa Ren; Jiandong Zhang; Nathan P Rudemiller; Robert Griffiths; Yi Wen; Xiaohan Lu; Jamie R Privratsky; Michael D Gunn; Steven D Crowley
Journal:  J Am Soc Nephrol       Date:  2019-07-17       Impact factor: 10.121

9.  Immunomodulatory and Mechanistic Considerations of Hibiscus sabdariffa (HS) in Dysfunctional Immune Responses: A Systematic Review.

Authors:  Francis U Umeoguaju; Benson C Ephraim-Emmanuel; Joy O Uba; Grace E Bekibele; Nwondah Chigozie; Orish Ebere Orisakwe
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

10.  CCL2 mediates early renal leukocyte infiltration during salt-sensitive hypertension.

Authors:  Ammar J Alsheikh; John Henry Dasinger; Justine M Abais-Battad; Daniel J Fehrenbach; Chun Yang; Allen W Cowley; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.